Urine and stool examination

Reading File
Do you want urine and stool examination as:
  1. Routine laboratory tests
  2. Specimen collection and procedure
  3. Interpretation of normal and abnormal findings
  4. Exam notes with tables and key points

Create a table of normal and abnormal findings

Reading File
Finding Sources
Finding Sources
Searching PubMed

urinalysis AND fecal examination

Searching the Web

urinalysis normal values stool examination normal findings laboratory manual

Reading File
Reading File
Reading Web Page

https://www.testing.com/tests/urinalysis

Urine examination

ParameterNormal findingAbnormal findingPossible significance
ColourPale yellow to amberDark yellow, red/pink, brown, orange, milkyDehydration; blood/hemoglobin; bilirubin; drugs/foods; pus or crystals
AppearanceClearCloudy/turbidCells, bacteria, crystals, mucus, or contamination
OdourSlightly aromaticFoul, fruity, ammoniacalUTI; ketones in diabetes/starvation; old specimen
Specific gravityAbout 1.005-1.030Low or highLow: dilute urine or impaired concentrating ability. High: dehydration, glucose, protein, contrast media
pHAbout 4.5-8.0, usually acidicPersistently alkaline or markedly acidicAlkaline: old specimen, urease-producing UTI, vegetarian diet. Acidic: ketoacidosis, diarrhea, high-protein diet
Protein/albuminNegative or traceProteinuriaRenal disease, fever, strenuous exercise, pre-eclampsia
GlucoseNegativeGlycosuriaDiabetes mellitus; rarely renal tubular disorders
KetonesNegativeKetonuriaDiabetic ketoacidosis, prolonged fasting, vomiting, starvation
BilirubinNegativeBilirubinuriaConjugated hyperbilirubinemia, hepatobiliary obstruction or liver disease
UrobilinogenSmall amount may be presentIncreased or absentIncreased: hemolysis or liver disease. Absent/low: complete biliary obstruction
Blood/hemoglobinNegativeHematuria or hemoglobinuriaStones, UTI, trauma, glomerular disease, tumor; hemolysis if hemoglobinuria
NitriteNegativePositiveSuggests nitrate-reducing bacterial UTI
Leukocyte esteraseNegativePositivePyuria, usually UTI or urinary inflammation
RBCs, microscopyNone to few, commonly 0-2/HPFIncreased RBCsHematuria from infection, stone, glomerular disease, malignancy, menstruation contamination
WBCs/pus cellsUsually 0-5/HPFIncreased WBCsUTI, interstitial nephritis, urinary inflammation
Epithelial cellsFew squamous cellsNumerous squamous or renal tubular cellsSquamous: contamination. Renal tubular cells: tubular injury
CastsNone, or occasional hyaline castsRBC, WBC, granular, waxy, epithelial castsRBC: glomerulonephritis. WBC: pyelonephritis/interstitial nephritis. Granular/epithelial: tubular injury. Waxy: chronic renal disease
CrystalsMay be absent or occasionalNumerous or characteristic crystalsMay suggest stone risk or metabolic disorder, depending on type
Bacteria/yeast/parasitesAbsentPresentUTI, candiduria, or contamination. Confirm suspected UTI with culture
Typical dipstick findings include clear urine with negative protein, glucose, ketones, blood, leukocyte esterase, nitrite, and bilirubin, but the laboratory reference range on the individual report should be used. Urinalysis reference

Stool examination

ParameterNormal findingAbnormal findingPossible significance
ColourBrownBlack/tarry, red, pale/clay, green, yellow/greasyBlack tarry: upper GI bleeding or iron/bismuth. Red: lower GI bleeding. Pale: reduced bile flow. Yellow/greasy: fat malabsorption
ConsistencySoft, formedWatery, loose, hard, greasy/bulkyWatery: diarrhea/infection. Hard: constipation. Greasy/bulky: steatorrhea, pancreatic insufficiency, malabsorption
FrequencyVariable, often 1-3 times/day to 3/weekPersistent diarrhea or constipationInfection, dietary/drug causes, functional or organic bowel disease
MucusAbsent or minimalVisible mucusColitis, inflammatory bowel disease, dysentery, infection
Visible bloodAbsentFresh red blood or altered dark bloodHemorrhoids, fissure, colitis, diverticular disease, colorectal lesion, GI bleeding
Occult blood testNegativePositiveGastrointestinal bleeding, including colorectal neoplasia, ulcers, or inflammation. Requires clinical follow-up
Pus cells/WBCsAbsentPresentInvasive bacterial diarrhea or inflammatory colitis
RBCs, microscopyAbsentPresentDysentery, invasive infection, inflammatory bowel disease, ischemic colitis
Ova, cysts, trophozoitesAbsentParasite forms presentIntestinal parasitic infection, such as amoebiasis or helminthiasis
Bacterial cultureNo enteric pathogen isolatedPathogen isolatedBacterial gastroenteritis, depending on organism and symptoms
Fat globulesAbsent or scantIncreased fecal fatMalabsorption, pancreatic exocrine insufficiency, celiac disease
Undigested muscle fibersAbsent or scantIncreased fibers (creatorrhea)Pancreatic insufficiency or rapid intestinal transit
Reducing substancesNegative, especially after infancyPositiveCarbohydrate malabsorption, most useful in pediatric assessment
Stool pHUsually neutral to mildly acidicLow pH, often <5.5Carbohydrate malabsorption with acidic diarrhea
YeastUsually absent/scantNumerous yeast cellsMay occur after antibiotics or with altered gut flora; interpretation needs symptoms and context
Important: A single abnormal finding does not establish a diagnosis. Sample collection, diet, medications, menstruation, hydration, and delay in processing can alter both urine and stool results. Black, tarry stool, visible blood in stool or urine, or urine with fever/flank pain should be assessed promptly.

If the stool has foul smell

Reading File
Finding Sources
Searching PubMed

foul smelling stool malabsorption

Searching the Web

foul smelling stool causes malabsorption infection authoritative health source

A foul-smelling stool can occur with a dietary change, but if it is persistently very offensive it may suggest:
Associated findingPossible cause
Bulky, pale, greasy, floating stool that is hard to flushFat malabsorption (steatorrhea), such as pancreatic insufficiency, celiac disease, or impaired bile flow
Watery diarrhea, bloating, cramps, and excess gas, especially after unsafe water exposureGiardiasis or another intestinal infection
Chronic diarrhea and weight lossMalabsorption or chronic intestinal disease
Blood, mucus, fever, or severe abdominal painInvasive intestinal infection or inflammatory bowel disease
Black tarry stoolPossible gastrointestinal bleeding, needing urgent assessment
Stools with steatorrhea are classically bulky, greasy, floating, and foul-smelling. Henry's Clinical Diagnosis and Management by Laboratory Methods notes that this pattern is characteristic of excess fat in stool. Foul-smelling diarrhea with flatulence lasting more than 2 weeks merits testing for Giardia.
See a clinician if the smell persists for more than a few days or occurs with weight loss, fever, dehydration, abdominal pain, blood, or pale/clay-colored stool. MedlinePlus guidance lists causes including infections, celiac disease, chronic pancreatitis, inflammatory bowel disease, cystic fibrosis, and malabsorption.

If the patient says when he excretes it smells and it looks almost solid but slightly mixes with water and colour change in water to stool colour

Reading File
Finding Sources
Finding Sources
Searching PubMed

chronic diarrhea stool consistency

Searching the Web

Bristol stool chart loose stools when to seek medical care official health

That description sounds like a soft to mushy, partly formed stool, rather than fully watery diarrhea. On the Bristol Stool Scale, it is often closest to:
  • Type 5: soft blobs with clear edges, or
  • Type 6: mushy stool with ragged edges.
A stool that looks nearly solid but partly disperses in toilet water, making the water brown, can be normal. Stool pigment and small soft particles commonly mix with the water. This alone does not prove infection, malabsorption, or bleeding.
The smell also varies with diet, bowel bacteria, and how long stool remains in the intestine. It becomes more concerning if it is persistently very foul and accompanied by:
  • Frequent loose stools, especially more than 3/day
  • Abdominal pain, fever, vomiting, bloating, or excess gas
  • Blood, mucus, black-tarry stool, or pale/clay-colored stool
  • Greasy, floating, bulky stool that is difficult to flush
  • Weight loss or poor appetite
  • Symptoms lasting more than 1-2 weeks
If there are no warning symptoms and this is occasional, advise adequate fluids and review recent food changes, antibiotics, dairy intolerance, or gastrointestinal upset. Persistently foul, loose stool with bloating and weight loss needs clinical evaluation, potentially including stool examination for infection or fat/parasites. MedlinePlus guidance lists diet changes as common, but also notes infections and malabsorption-related illnesses as possible causes.

What stool changes should prompt urgent medical care?

Reading File
Finding Sources
Finding Sources
Searching PubMed

acute diarrhea AND red flags

Searching the Web

adult diarrhea emergency warning signs blood black stools dehydration official health

Seek urgent medical care today if stool changes include any of the following:
Warning signWhy it matters
Black, tarry, sticky stoolMay indicate bleeding higher in the stomach or intestine
Bright-red blood, maroon stool, or blood clotsPossible intestinal bleeding
Pus or large amounts of mucus with diarrheaMay indicate a significant intestinal infection or inflammation
Severe or worsening abdominal pain, swollen abdomen, or rectal painCan indicate serious infection, obstruction, appendicitis, ischemia, or inflammation
Frequent vomiting or inability to keep fluids downRisk of rapid dehydration
Dehydration signs: very dry mouth, extreme thirst, dizziness/fainting, confusion, very dark urine, or much less urineMay require urgent fluid replacement
High fever, chills, marked weakness, or confusionPossible serious infection
Six or more loose stools in 24 hours, especially with weakness or dehydrationHigh fluid and electrolyte loss
Persistent diarrhea for more than 2 days in adultsNeeds assessment, especially if worsening
Pale/clay-colored stools, especially with yellow eyes/skin or dark urineMay suggest impaired bile flow or liver/biliary disease
Greasy, bulky, floating, very foul-smelling stools plus weight lossPossible fat malabsorption or pancreatic/bowel disease. Arrange prompt medical review
New change in bowel habit with unexplained weight loss, anemia, or fatigueNeeds medical evaluation for an underlying bowel disorder
Go to an emergency department now for black tarry stool, significant fresh blood, fainting/confusion, severe abdominal pain, severe dehydration, or inability to drink fluids.
Infants, young children, older adults, pregnant people, and people with weakened immunity or serious chronic illnesses should seek care earlier because dehydration and infection can become serious faster. The NIDDK diarrhea guidance lists blood or pus in stool, black stool, severe pain, frequent vomiting, altered mental state, and dehydration as reasons for prompt medical help.

How does stool turn black

Reading File
Finding Sources
Finding Sources
Searching PubMed

melena upper gastrointestinal bleeding

Searching the Web

black stool melena iron bismuth causes official health

Stool turns black mainly for two reasons:
  1. Digested blood, called melena
    • Bleeding from the food pipe, stomach, or upper small intestine exposes blood to stomach acid and digestive enzymes.
    • Hemoglobin is chemically altered as it travels through the gut, making stool jet black, tarry, sticky, and often very foul-smelling.
    • Causes include stomach or duodenal ulcers, gastritis, varices, or use of NSAID pain medicines such as ibuprofen, naproxen, and aspirin.
  2. Non-bleeding discoloration
    • Iron tablets
    • Bismuth medicines, such as Pepto-Bismol
    • Activated charcoal
    • Large amounts of black licorice, blueberries, or blood sausage
Black stool from iron or bismuth is usually formed and not tarry or sticky. They can darken stool without causing bleeding.
Seek emergency care now if black stool is tarry/sticky or occurs with dizziness, fainting, weakness, rapid heartbeat, abdominal pain, vomiting blood, or coffee-ground vomit. A clinician can test the stool for blood. MedlinePlus explains black stool causes.

Now explain me like a professor about alzheimer like a lecture

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

Alzheimer disease treatment

Searching the Web

2026 Alzheimer's disease diagnosis treatment anti amyloid FDA official

Searching Images

Alzheimer disease brain atrophy hippocampus amyloid plaque tau neurofibrillary tangle pathology diagram

Alzheimer Disease: A Short Clinical Lecture

1. What is Alzheimer disease?

Alzheimer disease is a progressive neurodegenerative brain disorder. It gradually damages neurons, especially those involved in memory, thinking, language, judgment, and everyday functioning.
It is the most common cause of dementia in older adults. Dementia is not one disease. It is a syndrome of decline in cognitive abilities severe enough to affect independent daily life. Alzheimer disease is one important cause of that syndrome.
The core clinical pattern is:
Gradual onset + slowly progressive decline, usually beginning with recent-memory impairment.
For example, a person may repeatedly ask the same question, forget recent conversations or appointments, misplace familiar objects, and later develop trouble managing money, medicines, travel, language, and self-care.

2. Normal ageing versus Alzheimer disease

Occasional forgetfulness is common with normal ageing. Alzheimer disease is suspected when memory difficulty is progressive and disrupts normal life.
Normal ageingSuggestive of Alzheimer disease
Occasionally forgets a name but remembers it laterRepeatedly forgets recent conversations or events
Misplaces an item occasionallyPuts items in unusual places and cannot retrace steps
Takes longer to learn a new taskCannot manage a familiar task, such as cooking or paying bills
Sometimes makes an incorrect decisionPersistent poor judgment, unsafe decisions, financial vulnerability
Forgets a word occasionallyIncreasing word-finding difficulty and impaired conversation
Remains independentNeeds help with medicines, finances, meals, hygiene, or navigation

3. What happens in the brain?

Two abnormal proteins are central to Alzheimer disease:

A. Amyloid-beta plaques

Amyloid-beta is a protein fragment. In Alzheimer disease, it accumulates outside neurons and forms sticky deposits called amyloid plaques.
Think of plaques as abnormal material accumulating between nerve cells. Their presence is associated with disruption of neuronal communication and activation of inflammatory cells in the brain.

B. Tau neurofibrillary tangles

Tau is normally an internal protein that helps stabilize microtubules, the internal transport tracks of neurons.
In Alzheimer disease, tau becomes abnormally phosphorylated, detaches from microtubules, and aggregates inside neurons as neurofibrillary tangles. The neuron then loses its transport system, malfunctions, and eventually dies.
A typical cerebrospinal-fluid biomarker pattern is low beta-amyloid with increased total tau and phosphorylated tau, reflecting amyloid deposition and neuronal injury.

C. Neuronal loss and brain atrophy

The disease often begins in the hippocampus and medial temporal lobe, regions needed for forming new memories. As damage progresses, it spreads to association areas of the cerebral cortex.
This produces:
  • Hippocampal and cerebral atrophy
  • Enlargement of brain ventricles and sulci on imaging
  • Loss of cholinergic neurons, which contributes to memory impairment
A simple sequence is:
Amyloid accumulation -> tau pathology -> synaptic dysfunction -> neuronal death -> brain shrinkage -> worsening cognition and function.
Amyloid is important, but the distribution and amount of tau pathology tend to correlate more closely with symptom severity.

4. Types of Alzheimer disease

Late-onset Alzheimer disease

  • Begins after age 65
  • Most common form
  • Usually multifactorial: age, vascular health, genetic susceptibility, lifestyle, and environment all contribute

Early-onset Alzheimer disease

  • Begins before age 65
  • Less common
  • May have a stronger genetic contribution
  • Rare inherited forms can involve pathogenic variants in APP, PSEN1, or PSEN2

APOE gene

The APOE ε4 allele increases risk but does not guarantee that a person will develop Alzheimer disease. Conversely, someone without APOE ε4 can still develop it. APOE testing is therefore not a stand-alone diagnostic test.

5. Clinical stages

Stage 1: Preclinical disease

Brain amyloid and/or tau changes may be present, but the individual has no obvious symptoms.

Stage 2: Mild cognitive impairment due to Alzheimer disease

There is measurable decline, often in recent memory, but the person remains mostly independent in daily activities.
Example: They may need more reminders or make mistakes with complex finances but still dress, eat, travel locally, and perform personal care independently.

Stage 3: Mild dementia

Symptoms interfere with independent living.
Common features:
  • Repetition of questions
  • Losing objects
  • Difficulty with planning, money management, medications, or driving
  • Word-finding problems
  • Trouble navigating unfamiliar places
  • Subtle personality or behavior change

Stage 4: Moderate dementia

There is increasing dependence.
Common features:
  • Significant memory loss
  • Disorientation to time and place
  • Difficulty recognizing familiar people at times
  • Agitation, wandering, suspiciousness, hallucinations, sleep disturbance
  • Need for help with dressing, bathing, meals, and continence

Stage 5: Severe dementia

The person becomes fully dependent.
Common features:
  • Very limited speech and recognition
  • Inability to walk independently later in the illness
  • Dysphagia, weight loss, aspiration risk
  • Urinary and fecal incontinence
  • Immobility, infections, pressure injury risk

6. Symptoms beyond memory loss

Alzheimer disease is not only a memory condition. It affects several cognitive domains.
DomainExamples of impairment
Episodic memoryForgetting recent events, repeating questions
Executive functionPoor planning, unsafe cooking, difficulty managing money
LanguageWord-finding difficulty, reduced fluency, later impaired comprehension
Visuospatial abilityGetting lost, misjudging distances, trouble recognizing objects
AttentionDifficulty following a conversation or completing multistep tasks
Behavior and moodApathy, irritability, depression, anxiety, agitation, suspiciousness
SleepDay-night reversal, fragmented sleep, nighttime wandering

7. How is Alzheimer disease diagnosed?

Diagnosis is clinical, supported by cognitive assessment, examination, laboratory studies, and selected biomarkers or imaging.

Step 1: History from patient and informant

A reliable family member or caregiver is important because the patient may not recognize the extent of decline.
Ask about:
  • Onset and progression
  • Memory, language, behavior, and daily functioning
  • Medication use, alcohol or substance use
  • Depression and sleep
  • Falls, gait changes, urinary symptoms
  • Family history
  • Impact on finances, cooking, driving, and medicines

Step 2: Cognitive assessment

Common tools include:
  • Mini-Mental State Examination, MMSE
  • Montreal Cognitive Assessment, MoCA
  • Mini-Cog
  • Formal neuropsychological testing when needed
These tests support assessment but do not diagnose Alzheimer disease by themselves.

Step 3: Look for reversible or alternative causes

Common initial investigations may include:
  • Complete blood count
  • Electrolytes, glucose, kidney and liver function
  • Thyroid-stimulating hormone
  • Vitamin B12, with other tests guided by history
  • Depression assessment
  • Medication review, especially sedatives, anticholinergic medicines, opioids, and alcohol

Step 4: Brain imaging

CT or MRI is used to exclude structural conditions such as tumor, subdural hematoma, hydrocephalus, or large stroke. MRI may also show hippocampal and medial temporal atrophy.

Step 5: Alzheimer biomarkers, when appropriate

Specialist evaluation may use:
  • Amyloid PET
  • Tau PET
  • Cerebrospinal-fluid amyloid and tau testing
  • Selected blood biomarker tests
In the United States, the FDA has cleared a blood test measuring the plasma pTau217/beta-amyloid 1-42 ratio as an aid to diagnosis in symptomatic adults aged 55 or older. It should be interpreted by clinicians within a full diagnostic assessment, not used as a screening test for everyone. FDA blood-test announcement

8. Important conditions that can mimic Alzheimer disease

Before labeling someone as having Alzheimer disease, consider:
  • Depression, sometimes called pseudodementia
  • Delirium from infection, dehydration, medication effects, or metabolic illness
  • Vascular cognitive impairment
  • Lewy body dementia
  • Frontotemporal dementia
  • Normal-pressure hydrocephalus
  • Hypothyroidism
  • Vitamin B12 deficiency
  • Sleep apnea
  • Hearing or visual impairment
  • Drug-induced cognitive impairment
Delirium is different: it begins suddenly, fluctuates over hours or days, and often includes impaired attention. Alzheimer disease usually develops gradually over months to years.

9. Treatment

There is no complete cure at present, but treatment can support function, reduce symptoms, improve safety, and in selected early cases modestly slow progression.

A. Medicines for cognitive symptoms

Drug groupExamplesMain role
Cholinesterase inhibitorsDonepezil, rivastigmine, galantamineMild to moderate disease; may give modest symptomatic benefit
NMDA receptor antagonistMemantineUsually moderate to severe disease; may be combined with a cholinesterase inhibitor
Cholinesterase inhibitors increase acetylcholine signaling. Common adverse effects include nausea, diarrhea, appetite or weight loss, vivid dreams, slow heart rate, and fainting. Use caution in patients with bradycardia, syncope, or certain conduction disorders.
Memantine modulates glutamate signaling. Possible adverse effects include dizziness, constipation, headache, and confusion.
These medicines are symptomatic treatments. They do not restore dead neurons or cure Alzheimer disease.

B. Anti-amyloid disease-modifying treatments

For carefully selected people with mild cognitive impairment or mild dementia due to confirmed Alzheimer pathology, anti-amyloid monoclonal antibodies may modestly slow cognitive and functional decline.
In the United States, these include:
  • Lecanemab
  • Donanemab
They require confirmation of brain amyloid pathology and planned MRI monitoring. Important risks include amyloid-related imaging abnormalities (ARIA), which can involve brain swelling or small brain hemorrhages. Risk assessment includes MRI findings, anticoagulant use, and APOE genotype in relevant settings. These drugs are not appropriate for advanced dementia and should be prescribed through a specialist service. Alzheimer’s Association treatment summary

C. Managing behavioral and psychological symptoms

Always first look for a trigger:
  • Pain
  • Constipation
  • Urinary infection or retention
  • Sleep deprivation
  • Medication adverse effects
  • Hunger, thirst, loneliness, overstimulation
  • Change of routine or unfamiliar environment
Use non-drug approaches first:
  • Calm, simple communication
  • Consistent routine
  • Adequate light in daytime and quiet at night
  • Familiar faces and objects
  • Hearing aids and eyeglasses when needed
  • Avoid arguing with delusions. Reassure and redirect.
  • Exercise and meaningful activity
Sedating medicines and antipsychotics are not routine first-line treatments. They can increase falls, stroke risk, and adverse effects, especially in older adults.

10. Caregiver and safety management

Good Alzheimer care involves the patient, family, caregivers, nurses, physicians, social workers, and occupational therapists.
Key areas include:
  • Medication supervision
  • Financial protection against errors and exploitation
  • Driving assessment, with earlier cessation if unsafe
  • Fall prevention and home safety
  • Identification bracelet or location plan for wandering risk
  • Nutrition, hydration, oral health, and constipation prevention
  • Advance care planning while the person can participate in decisions
  • Caregiver support and respite care
The aim is not just to treat memory loss. It is to preserve dignity, comfort, safety, relationships, and quality of life.

11. Risk reduction

No measure guarantees prevention, but several actions support brain and vascular health:
  • Control blood pressure, diabetes, and cholesterol
  • Do not smoke
  • Regular physical activity
  • Treat hearing loss
  • Maintain social and cognitive activity
  • Adequate sleep and treatment of sleep apnea if present
  • Balanced dietary pattern, such as Mediterranean-style eating
  • Limit excess alcohol
  • Manage depression and isolation

12. Key take-home points

  1. Alzheimer disease is a progressive neurodegenerative disorder and the leading cause of dementia.
  2. Early disease usually presents with impaired recent memory, followed by deficits in language, planning, orientation, and daily function.
  3. Its central pathology involves extracellular amyloid plaques and intracellular tau tangles.
  4. Diagnosis requires history, functional assessment, cognitive testing, examination, exclusion of reversible causes, and sometimes biomarkers.
  5. Donepezil, rivastigmine, galantamine, and memantine may offer symptomatic benefit.
  6. Lecanemab and donanemab may modestly slow decline in selected early, biomarker-confirmed cases but require specialist assessment and MRI safety monitoring.
  7. Safety measures, caregiver education, behavioral strategies, and advance planning are as important as medication.
If a person has new confusion over hours to days, fever, altered alertness, severe headache, weakness on one side, speech difficulty, or a sudden major change in behavior, treat it as possible delirium or stroke rather than assuming Alzheimer disease and seek urgent assessment.
This is a shared conversation. Sign in to Orris to start your own chat.